Human Saliva as a Non-Invasive Tool for Cancer Diagnostics Using Surface-Enhanced Raman Spectroscopy

Overview

About this study

The purpose of this study is to develop a rapid, reliable, inexpensive, and non-invasive method for cancer detection and screening. To use Surface-Enhanced Raman Spectroscopy (SERS), a powerful analytical technique that provides detailed and specific information at a molecular level, to detect cancer biomarkers in a patient’s saliva.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients ≥ 18 years of age.
Patients diagnosed with breast cancer or lung cancer.
Patients being treated at Mayo Clinic Health System - NWWI.
Healthy adults at Universtiy of Wisconsin Eau Claire.

Exclusion Criteria:

Patients without the specified cancer type.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 12/13/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Eau Claire, Wis. Mayo Clinic principal investigator Sandeep Basu, M.D.	Open for enrollment	Contact information: Linh Tran CCRP (715) 838-5871 Tran.Linh@mayo.edu

Mayo Clinic Location

Status

Contact

Eau Claire, Wis.

Mayo Clinic principal investigator

Sandeep Basu, M.D.

Open for enrollment

Contact information:

Linh Tran CCRP

(715) 838-5871

Tran.Linh@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials